Emerging Biomarker-Guided Therapies in Prostate Cancer

Prostate cancer remains one of the leading causes of cancer death in men worldwide. In the past decade, several new treatments for advanced prostate cancer have been approved. With a wide variety of available drugs, including cytotoxic agents, androgen receptor axis-targeted therapies, and alpha-emi...

Descripción completa

Detalles Bibliográficos
Autores principales: Deluce, Jasna E., Cardenas, Luisa, Lalani, Aly-Khan, Maleki Vareki, Saman, Fernandes, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319825/
https://www.ncbi.nlm.nih.gov/pubmed/35877260
http://dx.doi.org/10.3390/curroncol29070400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319825/
https://www.ncbi.nlm.nih.gov/pubmed/35877260
http://dx.doi.org/10.3390/curroncol29070400

Ejemplares similares